Eluting matrix and uses thereof

Invention Grant

US10580262B2 Eluting matrix and uses thereof 有权

Patent Title: Eluting matrix and uses thereof
Application No.: US15813917

Application Date: 2017-11-15
Publication No.: US10580262B2

Publication Date: 2020-03-03
Inventor: Mark C. Poznansky , Tao Chen
Applicant: The General Hospital Corporation
Applicant Address: US MA Boston
Assignee: The General Hospital Corporation
Current Assignee: The General Hospital Corporation
Current Assignee Address: US MA Boston
Agency: Myers Bigel, P.A.
Main IPC: G07F17/32
IPC: G07F17/32 ; A63F1/00 ; A63F1/06 ; A61K35/39 ; A61K9/50 ; A61L27/20 ; A61L27/38 ; C08L5/04 ; C08B37/00 ; C09D105/04 ; A61K38/19 ; A61K9/70 ; A61K38/13 ; A61K38/28 ; A61K35/12

Abstract:

CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.

Public/Granted literature

Information query

Espacenet

IPC分类: